Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Oncology·MeSH: Recurrence
Prevalence
3.2 / 100K
Incidence
3.2 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype?
There are 2 clinical trials targeting Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype tracked by BioSniper.
What is the prevalence of Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype?
The estimated prevalence of Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype is approximately 3.2 per 100,000 population.
Deep-dive into Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis